Physician
Nephrology
Dr. Stuart Bursten, MD
|
|
Give Review
Doctor Stuart Bursten, MD practices Nephrology. He went to medical school at Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He received awards:"Whos Who in Medicine and Healthcare". Stuart Bursten is a published MD. He has 37 papers published. The most current publication "Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma." Stuart Bursten accepts Medicare payments and is listed with Medicare.gov.
Publications
- Pharmacological inhibition of gelatinase B induction and tumor cell invasion.
- Pharmacological inhibition of phosphatidylcholine biosynthesis is associated With induction of phosphatidylinositol accumulation and cytolysis of neoplastic cell lines.
- Interleukin 1 and the glomerular mesangium. III. IL-1-dependent stimulation of mesangial cell protein kinase activity.
- High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography.
- CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo.
- CT-2576, an inhibitor of phospholipid signaling, suppresses constitutive and induced expression of human immunodeficiency virus.
- Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling Responses in cells.
- The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced Acute lung injury in pigs.
- Potential role for phosphatidic acid in mediating the inflammatory Responses to TNF alpha and IL-1 beta.
- Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced Renal cancer and malignant melanoma.
- Effects of lisofylline on hyperoxia-induced lung injury.
- Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid.
- Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice.
- Interaction of lipopolysaccharide With a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected ...
- Lisofylline causes rapid and prolonged suppression of serum levels of free fatty acids.
- Modulating phosphatidic acid Metabolism decreases oxidative injury in rat lungs.
- Lisofylline prevents leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally.
- Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets.
- Accumulation of glucosylceramides in multidrug-resistant cancer cells.
- An increase in serum C18 unsaturated free fatty acids as a predictor of the development of Acute respiratory distress syndrome.
- The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines Within the 16-kDa N-terminal propiece.
- Interleukin-1 stimulates phosphatidic acid-mediated phospholipase D activity in human mesangial cells.
- Lipid signal transduction pathways in angiotensin II type 1 receptor-transfected fibroblasts.
- A clinical scoring system for detection of patients With pheochromocytomas.
- Oral nifedipine for the treatment of patients With severe hypertension.
- Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.
- Activation of glomerular mesangial cells by gram-negative bacterial cell wall components.
- Rapid activation of phosphatidate phosphohydrolase in mesangial cells by lipid A.
- Mesangial cell activation by bacterial endotoxin. Induction of rapid cytoskeletal reorganization and gene expression.
- Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2.
- Interleukin-1 rapidly stimulates lysophosphatidate acyltransferase and phosphatidate phosphohydrolase activities in human mesangial cells.
- Lipid A activation of glomerular mesangial cells: mimicry of the bioactive lipid, phosphatidic acid.
- Lipid A stimulates phospholipase D activity in rat mesangial cells via a G-protein.
- Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues.
- Generation of phosphatidic acid and diacylglycerols following ligation of surface immunoglobulin in human B lymphocytes: potential role in PKC activation.
- Thermal lateral phase separations in bovine retinal rod outer segment membranes and phospholipids as evidenced by parinaric acid fluorescence polarization and energy t...
Schools
Yale University School Of Medicine
Boston City Hospital
University of Washington
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Internal Medicine
- Nephrology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
University of Washington -
Boston University Medical Center -
Yale University School of Medicine
Drug Facts
| NPI NUMBER | 1164494696 | |
| NPPES Provider LastName | BURSTEN | |
| NPPES Provider FirstName | STUART | |
| NPPES Provider ZIPCode | 945586417 | |
| NPPES Provider State | CA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 5062.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 321.0 | |
| Percent Opioid Claims | 6.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164494696 |
| Last Name Of The Provider | BURSTEN |
| First Name Of The Provider | STUART |
| View All |
Similar Doctors
|
Dr. Afsaneh Khalili, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Patricia F. Dizmang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Denise A. Yun, MD |
|
|
Dr. Edwin J. Chiu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer Gunnell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodney A. Block, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas T. Paukert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nagarathna G. Manjappa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debra Trnavsky-Hobbs, MD
This Doctor is OpenDoctor Recommended.
|